Literature DB >> 2848132

Mechanism of action of antitumor drug etoposide: a review.

J M van Maanen1, J Retèl, J de Vries, H M Pinedo.   

Abstract

Metabolism studies of the antitumor drug etoposide show the formation of metabolites in the lactone ring, which are probably not important for the drug's mechanism of action, and oxidative transformations in the dimethoxyphenol ring (E ring), which lead to products that can cause DNA damage and may play a role in the drug's mechanism of action. The cytotoxicity of etoposide is caused by the induction of DNA damage. The occurrence of the DNA lesions can be explained by the capacity of the drug to interfere with the scission-reunion reaction of mammalian topoisomerase II by stabilizing a cleavable complex.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2848132     DOI: 10.1093/jnci/80.19.1526

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  58 in total

1.  Synergistic suppression of apoptosis in salivary acinar cells by IGF1 and EGF.

Authors:  K H Limesand; K A Barzen; D O Quissell; S M Anderson
Journal:  Cell Death Differ       Date:  2003-03       Impact factor: 15.828

Review 2.  Potential of plant-derived natural products in the treatment of leukemia and lymphoma.

Authors:  David M Lucas; Patrick C Still; Lynette Bueno Pérez; Michael R Grever; A Douglas Kinghorn
Journal:  Curr Drug Targets       Date:  2010-07       Impact factor: 3.465

3.  MCL-1 localizes to sites of DNA damage and regulates DNA damage response.

Authors:  Sarwat Jamil; Cezar Stoica; Tillie-Louise Hackett; Vincent Duronio
Journal:  Cell Cycle       Date:  2010-07-11       Impact factor: 4.534

Review 4.  Nuclear initiated NF-κB signaling: NEMO and ATM take center stage.

Authors:  Shigeki Miyamoto
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

5.  Topoisomerase poisons activate the transcription factor NF-kappaB in ACH-2 and CEM cells.

Authors:  B Piret; J Piette
Journal:  Nucleic Acids Res       Date:  1996-11-01       Impact factor: 16.971

6.  Inhibition of replicon initiation in human cells following stabilization of topoisomerase-DNA cleavable complexes.

Authors:  W K Kaufmann; J C Boyer; L L Estabrooks; S J Wilson
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

7.  Which therapy works better in choroid plexus carcinomas?

Authors:  Su G Berrak; Diane D Liu; Brigitte Wrede; Johannes E Wolff
Journal:  J Neurooncol       Date:  2010-10-26       Impact factor: 4.130

8.  Antiproliferative cardenolides from Pentopetia androsaemifolia Decne. from the Madagascar rain forest.

Authors:  Eba Adou; James S Miller; Fidisoa Ratovoson; Chris Birkinshaw; Rabodo Andriantsiferana; Vincent E Rasamison; David G I Kingston
Journal:  Indian J Exp Biol       Date:  2010-03       Impact factor: 0.818

9.  N-myc amplification and its relationship to experimental therapy.

Authors:  A Livingstone; R J Mairs
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

10.  Shwachman-Bodian Diamond syndrome is a multi-functional protein implicated in cellular stress responses.

Authors:  Heather L Ball; Bing Zhang; J Jacob Riches; Rikesh Gandhi; Jing Li; Johanna M Rommens; Jeremy S Myers
Journal:  Hum Mol Genet       Date:  2009-07-14       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.